CVS Pharmacy and its subsidiaries have agreed to pay $315 million to settle a US Department of Justice lawsuit alleging that the pharmacy chain unlawfully dispensed opioid prescriptions that were not needed medically. The settlement, announced on October 13, also requires the company to implement safeguards against inappropriate and unnecessary dispensing.Filed in December 2024, the lawsuit alleged that CVS dispensed prescriptions that lacked a legitimate medical purpose, involved excessive quantities of opioids or were dispensed too early. The government also alleged that the company filled prescriptions from so-called “pill mills”, suppliers who are accused of issuing large numbers of controlled-substance prescriptions without a legitimate medical purpose. CVS has strongly disputed the allegations and denies any wrongdoing as part of the settlement. The agreement resolves the civil claims without a determination of liability.Unsafe Opioid Prescriptions Can Increase Addiction RiskAlso read: Why Is The US Fast Tracking Trials Of Ibogaine, A Schedule I Controlled Substance, Despite Safety RisksOpioids are powerful medications used to treat moderate to severe pain. They include prescription drugs like oxycodone, hydrocodone and morphine. When prescribed appropriately and taken under medical supervision, they can provide important relief. However, their effects on the brain'can also lead to dependence and addiction issues.Dependence and addiction are related but different. Physical dependence occurs when the body adapts to a medication. If stopped abruptly, one may experience severe withdrawal symptoms. Opioid use disorder, commonly referred to as opioid addiction, involves a destructive pattern that can include cravings, loss of control and continued use despite harmful consequences.The risk increases when these opioids are prescribed or taken in excessive doses or combined with other similar medicines. Taking more than prescribed can also increase the risk of overdose, which can slow or stop breathing and may be fatal.The Justice Department's lawsuit alleged that CVS dispensed prescriptions for dangerous combinations of medicines, including “trinity” prescriptions combining an opioid, a benzodiazepine and a muscle relaxant. Such combinations can lead to a compounded sedation effect and respiratory depression, increasing the risk of serious harm.In these cases, addiction becomes more than just a habit. These substances alter brain chemistry, particularly in the areas related to reward, motivation, and self-control. Hence, recovery is not simply about choosing to quit.Addiction hijacks the brain’s prefrontal cortex—the area responsible for decision-making, self-control, and judgment. As a result, people suffering from addiction are often unable to regulate their behavior, even when they want to.The brain’s reward system reinforces substance use by releasing dopamine, the chemical associated with pleasure and reward. Over time, the brain becomes dependent on this chemical surge, leading to tolerance (needing more of the substance to feel the same effect) and withdrawal symptoms when the substance is not available.Also read: ‘Zombie’ Drug Medetomidine, Spotted In Heroin Supply, Raises Concern As It Could Evade Overdose AntidoteWhat Did The Lawsuit Allege? According to the Justice Department, the alleged dispensing practices occurred between October 2013 and December 2025. The government claimed that staffing shortages, performance targets and incentive policies contributed to pharmacists filling prescriptions without adequately checking whether they were legitimate.Many of the prescriptions were allegedly billed to federal healthcare programmes, including Medicare and Medicaid, prompting claims under the federal False Claims Act as well as the Controlled Substances Act.“Today's settlement is a significant milestone in the Justice Department's efforts to combat the opioid epidemic by cracking down on pharmacies who unlawfully fulfill prescriptions for controlled substances,” Associate Attorney General Stanley Woodward said in a statement.CVS said its pharmacists were trained “in the safe and appropriate use of all medications” and that the company had introduced programmes to help them make appropriate decisions for patients.